SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:131872665"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:131872665" > Whole Exome- and mR...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002903naa a2200325 4500
001oai:prod.swepub.kib.ki.se:131872665
003SwePub
008240701s2015 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1318726652 URI
024a https://doi.org/10.1155/2015/8620392 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Sandgren, Ju Karolinska Institutet4 aut
2451 0a Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency
264 1b Hindawi Limited,c 2015
520 a Background. AT/RTs are rare aggressive brain tumours, mainly affecting young children. Most cases present with genetic inactivation ofSMARCB1, a core member of the SWI/SNF chromatin-remodeling complex. We have performed whole exome- and mRNA-sequencing on an early onset AT/RT case for detection of genetic events potentially contributing to the disease.Results. Ade novogermline variant inSMARCB1, c.601C>T p.Arg201∗, in combination with somatic deletion of the healthy allele is likely the major tumour causing event. Only seven somatic small scale mutations were discovered (hittingSEPT03, H2BFM, ZIC4, HIST2H2AB, ZIK1, KRTAP6-3, andIFNA8). All were found with subclonal allele frequencies (range 5.7–17%) and none were expressed. However, besidesSMARCB1, candidate genes affected by predicted damaging germline variants that were expressed were detected (KDM5C, NUMA1, andPCM1). Analysis of differently expressed genes revealed many dysregulated pathways in the tumour, such as cell cycle, CXCR4 pathway, GPCR-signalling, and neuronal system.FGFR1, CXCR4, andMDKwere upregulated and may represent possible drug targets.Conclusion. The loss ofSMARCB1function leads to AT/RT development and deregulated genes and pathways. Additional predisposing events may however contribute. Studies utilizing NGS technologies in larger cohorts will probably identify recurrent genetic and epigenetic alterations and molecular subgroups with implications for clinical practice and development of targeted therapies.
700a Holm, S4 aut
700a Marino, AM4 aut
700a Asmundsson, Ju Karolinska Institutet4 aut
700a Grillner, Pu Karolinska Institutet4 aut
700a Nister, Mu Karolinska Institutet4 aut
700a de Stahl, TDu Karolinska Institutet4 aut
710a Karolinska Institutet4 org
773t BioMed research internationald : Hindawi Limitedg 2015, s. 862039-q 2015<862039-x 2314-6141x 2314-6133
856u http://downloads.hindawi.com/journals/bmri/2015/862039.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:131872665
8564 8u https://doi.org/10.1155/2015/862039

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view